» Articles » PMID: 21195181

Serine Recombinases As Tools for Genome Engineering

Overview
Journal Methods
Specialty Biochemistry
Date 2011 Jan 4
PMID 21195181
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

The serine recombinases differ mechanistically from the tyrosine recombinases and include proteins such as ϕC31 integrase which, unlike Cre and Flp, promote unidirectional reactions. The serine recombinase family is large and includes many other proteins besides ϕC31 integrase with the potential to be widely used in genome engineering. Here we review the details of the mechanism of the reactions promoted by the serine recombinases and discuss how these not only limit the utility of this class of recombinase but also creates opportunities for the engineering of new enzymes. We discuss the unanswered questions posed by genome engineering experiments in a variety of systems in which the serine recombinases have been used and finally describe more recently discovered serine recombinases that have the potential to be used in genome engineering.

Citing Articles

There and turn back again: the application of phage serine integrases in eukaryotic systems.

Sales T, de Oliveira M, Florentino L, Lima R, Rech E Front Bioeng Biotechnol. 2025; 13:1478413.

PMID: 40066361 PMC: 11891168. DOI: 10.3389/fbioe.2025.1478413.


Engineering structural variants to interrogate genome function.

Koeppel J, Weller J, Vanderstichele T, Parts L Nat Genet. 2024; 56(12):2623-2635.

PMID: 39533047 DOI: 10.1038/s41588-024-01981-7.


Recent Advances in Genetic Engineering Strategies of .

Liu X, Dong H, Wang H, Ren X, Yang X, Li T ACS Synth Biol. 2024; 13(11):3497-3506.

PMID: 39481116 PMC: 11574922. DOI: 10.1021/acssynbio.4c00348.


STRAIGHT-IN Dual: a platform for dual, single-copy integrations of DNA payloads and gene circuits into human induced pluripotent stem cells.

Blanch-Asensio A, Ploessl D, Wang N, Mummery C, Galloway K, Davis R bioRxiv. 2024; .

PMID: 39464154 PMC: 11507887. DOI: 10.1101/2024.10.17.616637.


STRAIGHT-IN: a platform for rapidly generating panels of genetically modified human pluripotent stem cell lines.

Blanch-Asensio A, Grandela C, Mummery C, Davis R Nat Protoc. 2024; .

PMID: 39179886 DOI: 10.1038/s41596-024-01039-2.